Juxtapid Capsule
Product Images NDC 10122-430

This text provides information about a medication called Juxtapid containing 30mg of lomitapide per capsule. The dosage instructions are available in the package insert. The active ingredient is lomitapide, and the capsules should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 85°F). The medication is manufactured for Chiesi Farmaceutici S.p.A. in Italy. Additionally, it is advised to keep the container tightly closed and protected from moisture. The prescription is for capsules and should be dispensed to patients with the accompanying Medication Guide.*

This is not-available.*

This text provides information on a medication called Juxtapid (lomitapide) capsules, containing 5 mg of lomitapide per capsule. It gives storage instructions, dosage and use guidelines, a note to keep out of reach of children, and mentions the manufacturer as Chiesi Farmaceutici S.p.A. from Parma, Italy. The National Drug Code (NDC) for this medication is 10122-405-28, and it comes in a package with 28 capsules. It is also indicated for prescription use only. Remember to check the package insert for detailed usage instructions and dispense the accompanying Medication Guide to each patient.*

This is a description of medication called "Juxtapid" which contains 5 mg of active ingredient lomitapide per capsule. It is labeled for Rx Only and should be stored between 15°C and 30°C. The medication is intended for adult use only and comes with a medication guide for each patient. It is important to keep the capsules out of reach of children. For detailed dosage and usage instructions, refer to the package insert provided.*

Each capsule contains 10 mg of lomitapide. It is recommended to store the medication at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Remember to keep the container tightly closed and protect it from moisture. This product is manufactured by Chiesi Farmaceutid S.p.A. in Parma, Italy. The medication is available in a package of 28 capsules labeled Juxtapid. For dosage and usage instructions, refer to the package insert. It is important to dispense the accompanying Medication Guide to each patient.*

This is not-available.*

This text provides information about a medication called Juxtapid, specifically lomitapide capsules containing 20 mg each. The storage instructions recommend keeping it out of reach of children, storing between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (between 59°F and 86°F). It is advised to keep the capsules tightly closed and protected from moisture. The manufacturer is Chiesi Farmaceutici S.p.A. in Parma, Italy. The National Drug Code (NDC) for this medication is 10122-420-28. The text also suggests referring to the package insert for dosage and use guidelines, and dispensing the accompanying Medication Guide to each patient.*

The text provides information about a medication called Juxtapid (lomitapide) in capsule form with a dosage of 20 mg lomitapide per capsule. It also includes storage instructions, mentioning to keep the container tightly closed and protected from moisture. Additionally, it indicates that the medication is for prescription use only and includes details on the manufacturer, Chiesi Farmaceutici S.p.A. in Parma, Italy. The dosage and specific use instructions are advised to be referenced from the package insert.*

This text provides important information about a medication called Juxtapid. Each capsule contains 30 mg of lomitapide. It is crucial to keep this medication out of reach of children, store it between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (between 59°F and 86°F), keep tightly closed and protect from moisture. It is manufactured by Chiesi Farmaceutici S.p.A. in Parma, Italy. The NDC number for this medication is 10122-430-28, and it comes in a packaging of 28 capsules. The text also includes a prescription symbol (Rx only) and encourages referring to the package insert for dosage and use guidance, as well as dispensing the accompanying Medication Guide to each patient.*